Status:
RECRUITING
Evaluation of Macular Edema After AcF Implant's Injection, 1 Month After the Last DXM Implant
Lead Sponsor:
Nantes University Hospital
Conditions:
Macular Edema
Eligibility:
All Genders
18+ years
Brief Summary
Patients with diabetic macular edema (DME) or uveitis-related macular edema who have failed first-line therapy such as anti-VEGF, laser treatments, or dexamethasone implants (DXM) are candidates for t...
Eligibility Criteria
Inclusion
- Patient (Male, Female)°≥ 18 years old
- Having received an AcF injection 1 month after a DXM injection
- For diabetic macular edema or uveitic macular edema
Exclusion
- Patient's refusal to allow his or her medical data to be used for research purposes
Key Trial Info
Start Date :
January 9 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT05996822
Start Date
January 9 2024
End Date
June 1 2024
Last Update
February 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jean-Baptiste Ducloyer
Nantes, France, 44093